ASX:PYC
PYC is dedicated to changing the lives of patients with rare genetic diseases – a unique opportunity in drug development
Very powerful rounding bottom formation, manage the multiyear high and closed above that.
Manage to close above the Jan 2010 high, close to 127 months.
Given the massive run close to 3X in last one year.
Downside -...
PYC Therapeutics Ltd. is a drug-development company, which offers a new generation of RNA therapeutics to meet unmet need in disease. It develops intracellular biological therapeutics including its own preclinical oncology payloads, using its proprietary cell Functional Penetrating Phylomers. The company was founded by Richmond Miles Hopkins and Paul Michael Watt on October 9, 2001 and is headquartered in Nedlands, Australia.
ASX
